Search results
FDA Approves First mRNA RSV Vaccine
MedPage Today· 5 days agoThe vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine< ...
Anthony Fauci faces questions during contentious COVID-19 hearing in the House
USA TODAY via Yahoo News· 1 day agoRichard McCormick, R-Ga. “Americans were aggressively bullied, shamed and silenced for debating...
The Push to Get More People Into Long COVID Studies
Medscape· 1 day agoSince then, it's been a tough road for Spier, 37, who said he wouldn't wish his hellish condition on anyone. Last spring, he enrolled in a clinical trial...
Unpacking Averages: Growth of AL/ML in Medicine as Evidenced by Clinical Trials | JD Supra
JD Supra· 22 hours agoMost people have seen the growth in artificial intelligence/ machine learning (AI/ML)-based medical devices being cleared by FDA.
Small Business - Picayune Item | Picayune Item
The Picayune Item· 22 hours agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies
Fauci denies seeking to suppress COVID-19 lab leak origin theory
Fox News via Yahoo News· 2 days agoThe next day, Fauci said, he participated in a conference call "with about a dozen international...
Fauci testifies about COVID pandemic response at heated House hearing
CBS News· 2 days agoDr. Anthony Fauci testified on Monday before a Republican-led House panel investigating the origins...
Key takeaways: Fauci defends against GOP claims on COVID origins, response
Good Morning America via Yahoo News· 1 day agoFauci previously proclaimed that he had "nothing to hide" and came before the Select Subcommittee on...
La Jolla News Nuggets: Track and field titles; coyotes; Business People of the Year; COVID research;...
La Jolla Light· 1 day agoLa Jolla High School’s Payton Smith overcame a foot injury to win the girls 400-meter gold medal at...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
St. Joseph News-Press· 7 days agoNo matter how much a virus changes in the field, it uses the same "landing sites" in the host body...